Carbamazepine and DOAC — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Carbamazepine may reduce rivaroxaban exposure and anticoagulant effect
Carbamazepine is a strong enzyme inducer and can reduce exposure to some DOACs. The prescriber should review anticoagulant choice because treatment failure may lead to stroke. The other options either delay appropriate care, use an unsuitable medicine, or miss the main safety issue.
Reference: BNF